中文
中文
为了病患而驱动的创新
Patient-first cell therapy innovation

科学论文
SCIENTIFIC PUBLICATION
  • 11.032021
    Cancer Cell-Derived GABA Promotes β-Catenin-Mediated Tumor Growth and Immunosuppression.
    Huang D., Wang Y., Thompson J.W., Yin T., Alexander P.B., Qin D., Mudgal P., Wu H., Liang Y., Tan L., Pan C., Yuan L., Wan Y., Li Q.-J.,* and Wang X.F. (2021) Cancer Cell-Derived GABA Promotes β-Catenin-Mediated Tumor Growth and Immunosuppre
  • 11.022021
    The lupus autoantigen La/Ssb is an Xist-binding protein involved in Xist folding and cloud formation.
    Ha N., Ding N., Hong R., Liu R., Roca X., Luo Y., Duan X., Wang X., Ni P., Wu H., Zhang L.F.*, Chen L*. (2021)The lupus autoantigen La/Ssb is an Xist-binding protein involved in Xist folding and cloud formation. Nucleic Acids Res. (20):11596-11613. (
  • 10.262021
    TIPS: trajectory inference of pathway significance through pseudotime comparison for functional assessment of single-cell RNAseq data.
    Zheng Z., Qiu X., Wu H., Chang L., Tang X., Zou L., Li J., Wu Y., Zhou J., Jiang S., Wan Y., Ni Q. (2021) TIPS: trajectory inference of pathway significance through pseudotime comparison for functional assessment of single-cell RNAseq data. Brief Bio
  • 10.182021
    TCR repertoire characteristics predict clinical response to adoptive CTL therapy against nasopharyngeal carcinoma.
    Wang G., Mudgal P., Wang L., Shuen T.W.H., Wu H., Alexander P.B., Wang W.W., Wan Y., Toh H.C.*, Wang X.-F.*, and Li Q.-J.* (2021) TCR repertoire characteristics predict clinical response to adoptive CTL therapy against nasopharyngeal carcinoma. Oncoi
  • 10.052021
    Resident Memory T Cells in Tumor-Distant Tissues Fortify Against Metastasis Formation.
    Christian L.S., Wang L., Wu H., Deng D., Lim B., Wang X.-F. and Li Q.-J. (2021) Resident Memory T Cells in Tumor-Distant Tissues Fortify Against Metastasis Formation. Cell Reports 35(6)109118 (PMCID: PMC8204287)https://www.ncbi.nlm.nih.gov/pmc/articl
  • 09.282021
    Peripheral eosinophil counts predict efficacy of anti-CD19 CAR-T cell therapy against B-lineage non-Hodgkin lymphoma.
    Jia Q., Qin D., He F., Xie Q., Ying Z., Zhang Y., Song Y., Cheng J.N., Zuo X., Xu L., Fang H., Hu C., Peng L., Jin T., Shi Z., Alexander P.B., Wang Y., Liu Y., Han W., Zhu J., Wang P.*, Li Q.-J.*, Zhu B.* (2021) Peripheral eosinophil counts predict e
123
查看更多

Copyright © 2019 天科雅生物医药科技有限公司

粤公网安备 44011502000528号

粤ICP备20056630号 Powered by vancheer
关于天科雅
研究与发展
产品及临床
新闻与媒体
招贤纳士

Copyright © 2019 天科雅生物医药科技有限公司

粤公网安备 44011502000528号

粤ICP备20056630号 Powered by vancheer